-
Something wrong with this record ?
Identification of likely associations between cerebral folate deficiency and complex genetic- and metabolic pathogenesis of autism spectrum disorders by utilization of a pilot interaction modeling approach
D. Krsička, J. Geryk, M. Vlčková, M. Havlovicová, M. Macek, R. Pourová,
Language English Country United States
Document type Journal Article
PubMed
28339176
DOI
10.1002/aur.1780
Knihovny.cz E-resources
- MeSH
- Databases, Factual MeSH
- Humans MeSH
- Brain metabolism MeSH
- Folic Acid Deficiency complications MeSH
- Autism Spectrum Disorder complications metabolism MeSH
- Models, Theoretical * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Recently, cerebral folate deficiency (CFD) was suggested to be involved in the pathogenesis of autism spectrum disorders (ASD). However, the exact role of folate metabolism in the pathogenesis of ASD, identification of underlying pathogenic mechanisms and impaired metabolic pathways remain unexplained. The aim of our study was to develop and test a novel, unbiased, bioinformatics approach in order to identify links between ASD and disturbed cerebral metabolism by focusing on abnormal folate metabolism, which could foster patient stratification and novel therapeutic interventions. An unbiased, automatable, computational workflow interaction model was developed using available data from public databases. The interaction network model of ASD-associated genes with known cerebral expression and function (SFARI) and metabolic networks (MetScape), including connections to known metabolic substrates, metabolites and cofactors involving folates, was established. Intersection of bioinformatically created networks resulted in a limited amount of interaction modules pointing to common disturbed metabolic pathways, linking ASD to CFD. Two independent interaction modules (comprising three pathways) covering enzymes encoded by ASD-related genes and folate cofactors utilizing enzymes were generated. Module 1 suggested possible interference of CFD with serine and lysine metabolism, while module 2 identified correlations with purine metabolism and inosine monophosphate production. Since our approach was primarily conceived as a proof of principle, further amendments of the presented initial model are necessary to obtain additional actionable outcomes. Our modelling strategy identified not only previously known interactions supported by evidence-based analyses, but also novel plausible interactions, which could be validated in subsequent functional and/or clinical studies. Autism Res 2017, 10: 1424-1435. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18025112
- 003
- CZ-PrNML
- 005
- 20180712091430.0
- 007
- ta
- 008
- 180709s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/aur.1780 $2 doi
- 035 __
- $a (PubMed)28339176
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krsička, Daniel $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06 Prague, Czech Republic.
- 245 10
- $a Identification of likely associations between cerebral folate deficiency and complex genetic- and metabolic pathogenesis of autism spectrum disorders by utilization of a pilot interaction modeling approach / $c D. Krsička, J. Geryk, M. Vlčková, M. Havlovicová, M. Macek, R. Pourová,
- 520 9_
- $a Recently, cerebral folate deficiency (CFD) was suggested to be involved in the pathogenesis of autism spectrum disorders (ASD). However, the exact role of folate metabolism in the pathogenesis of ASD, identification of underlying pathogenic mechanisms and impaired metabolic pathways remain unexplained. The aim of our study was to develop and test a novel, unbiased, bioinformatics approach in order to identify links between ASD and disturbed cerebral metabolism by focusing on abnormal folate metabolism, which could foster patient stratification and novel therapeutic interventions. An unbiased, automatable, computational workflow interaction model was developed using available data from public databases. The interaction network model of ASD-associated genes with known cerebral expression and function (SFARI) and metabolic networks (MetScape), including connections to known metabolic substrates, metabolites and cofactors involving folates, was established. Intersection of bioinformatically created networks resulted in a limited amount of interaction modules pointing to common disturbed metabolic pathways, linking ASD to CFD. Two independent interaction modules (comprising three pathways) covering enzymes encoded by ASD-related genes and folate cofactors utilizing enzymes were generated. Module 1 suggested possible interference of CFD with serine and lysine metabolism, while module 2 identified correlations with purine metabolism and inosine monophosphate production. Since our approach was primarily conceived as a proof of principle, further amendments of the presented initial model are necessary to obtain additional actionable outcomes. Our modelling strategy identified not only previously known interactions supported by evidence-based analyses, but also novel plausible interactions, which could be validated in subsequent functional and/or clinical studies. Autism Res 2017, 10: 1424-1435. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.
- 650 _2
- $a poruchy autistického spektra $x komplikace $x metabolismus $7 D000067877
- 650 _2
- $a mozek $x metabolismus $7 D001921
- 650 _2
- $a databáze faktografické $7 D016208
- 650 _2
- $a nedostatek kyseliny listové $x komplikace $7 D005494
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a teoretické modely $7 D008962
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Geryk, Jan $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06 Prague, Czech Republic.
- 700 1_
- $a Vlčková, Markéta $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06 Prague, Czech Republic.
- 700 1_
- $a Havlovicová, Markéta $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06 Prague, Czech Republic.
- 700 1_
- $a Macek, Milan $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06 Prague, Czech Republic.
- 700 1_
- $a Pourová, Radka $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06 Prague, Czech Republic.
- 773 0_
- $w MED00157624 $t Autism research official journal of the International Society for Autism Research $x 1939-3806 $g Roč. 10, č. 8 (2017), s. 1424-1435
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28339176 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180712091723 $b ABA008
- 999 __
- $a ok $b bmc $g 1317243 $s 1022033
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 10 $c 8 $d 1424-1435 $e 20170324 $i 1939-3806 $m Autism research $n Autism Res $x MED00157624
- LZP __
- $a Pubmed-20180709